Long‐term outcome of 2‐year survivors after allogeneic hematopoietic cell transplantation for acute leukemia

Documenti analoghi

• Improved post‐transplant outcomes since 2000 for Ph‐positive acute lymphoblastic leukemia in first remission: A study from the EBMT Acute Leukemia Working Party
  di: Ali Bazarbachi, et al.
  Pubblicazione: (2025)
• Childhood myelodysplastic syndromes: Is cytoreductive therapy useful before allogeneic hematopoietic stem cell transplantation?
  di: Baptiste Le Calvez, et al.
  Pubblicazione: (2024)
• Who owns that blood? Recontacting donors with results from genetic testing after allogeneic hematopoietic cell transplantation
  di: Mirjam E. Belderbos, et al.
  Pubblicazione: (2025)
• HLA evolutionary divergence score after donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantation
  di: Sophie Le Grand, et al.
  Pubblicazione: (2025)
• Prospective phase II study of allogeneic hematopoietic stem cell transplantation with targeted busulfan, fludarabine, and etoposide conditioning in pediatric acute lymphoblastic leukemia
  di: Kyung Taek Hong, et al.
  Pubblicazione: (2024)